Ibritumomab Intravenous and Selegiline
Determining the interaction of Ibritumomab Intravenous and Selegiline and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Selegiline Capsules and Tablets
- Ibritumomab Intravenous-Selegiline Hydrochloride
- Ibritumomab Intravenous-Selegiline Oral
- Ibritumomab Intravenous-Selegiline Orally Disintegrating Tablets
- Ibritumomab Intravenous-Selegiline Tablets
- Ibritumomab Intravenous-Selegiline transdermal
- Selegiline-Ibritumomab Tiuxetan
- Selegiline-Ibrutinib
- Selegiline-Ibrutinib Capsules
- Selegiline-Ibrutinib Tablets
- Selegiline-Ibu
- Selegiline-IBU Tablets